Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples